Chief Commercial Officer · DBV Technologies S.A. · DBV Technologies S.A. — Employee Stock Option (right to buy)
Grant or award — administrative, little informational value
No reported dollar value · new position
Disclosed 1 business day after execution (deadline: 2)
First recorded trade by this actor in this security
No clustered activity in the dataset
No material company filing within 60 days after the trade
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 13 | Mohideen PharisChief Medical Officer | Grant or award | A | — 44.0K sh | Nov 25, 2025 traded Nov 21, 2025 | |
| 31 | Mohideen PharisChief Medical Officer | Open-market sale | SELL | $19K 6,496 sh | Nov 25, 2025 traded Nov 20, 2025 | |
| 17 | Mohideen PharisChief Medical Officer | Open-market sale | SELL | $4,498 1,624 sh | Nov 25, 2025 traded Nov 21, 2025 | |
| 5 | Mohideen PharisChief Medical Officer | Grant or award | A | — 253.0K sh | Nov 25, 2025 traded Nov 21, 2025 | |
| 9 | Boucinha VirginieChief Financial Officer | Grant or award | A | — 192.0K sh | Nov 24, 2025 traded Nov 21, 2025 | |
| 21 | Boucinha VirginieChief Financial Officer | Grant or award | A | — 32.0K sh | Nov 24, 2025 traded Nov 21, 2025 | |
| 9 | Trapp Kevin MichaelChief Commercial Officer | Grant or award | A | — 55.0K sh | Nov 24, 2025 traded Nov 21, 2025 |
Read directly from the primary public document; every field below is as reported by the filer.
Trapp Kevin Michael filed this Form 4 reporting a grant or award of DBVT on Nov 21, 2025. It became public on Nov 24, 2025. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.
No field has changed since this record was first ingested.
No material filings recorded for this issuer.